Akebia Therapeutics reported $0 in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Agios Pharmaceuticals AGIO:US USD 1.06M 0
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Amgen AMGN:US USD 37.16B 1.46B
Astellas Pharma 4503:JP JPY 82.39B 29.23B
AstraZeneca AZN:LN USD 23.68B 3.47B
Bayer BAYN:GR EUR 39.46B 1.4B
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Fresenius Medical Care FME:GR EUR 12.41B 930M
GlaxoSmithKline GSK:LN GBP 19.32B 538M
Intercept Pharmaceuticals ICPT:US USD 222.86M 491M
Ironwood Pharmaceuticals IRWD:US USD 395.85M 399K
Karyopharm Therapeutics KPTI:US USD 302.89M 201K
Moderna Inc MRNA:US USD 922M 281M
Ptc Therapeutics PTCT:US USD 981.61M 165K
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Roche Holding ROG:VX 22.37B 6.29B
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M